Ramasamy, Maheshi N; Minassian, Angela M; Ewer, Katie J; Flaxman, Amy L; Folegatti, Pedro M; Owens, Daniel R; Voysey, Merryn; Aley, Parvinder K; Angus, Brian; Babbage, Gavin; Belij-Rammerstorfer, Sandra; Berry, Lisa; Bibi, Sagida; Bittaye, Mustapha; Cathie, Katrina; Chappell, Harry; Charlton, Sue; Cicconi, Paola; Clutterbuck, Elizabeth A; Colin-Jones, Rachel; Dold, Christina; Emary, Katherine R W; Fedosyuk, Sofiyah; Fuskova, Michelle; Gbesemete, Diane; Green, Catherine; Hallis, Bassam; Hou, Mimi M; Jenkin, Daniel; Joe, Carina C D; Kelly, Elizabeth J; Kerridge, Simon; Lawrie, Alison M; Lelliott, Alice; Lwin, May N; Makinson, Rebecca; Marchevsky, Natalie G; Mujadidi, Yama; Munro, Alasdair P S; Pacurar, Mihaela; Plested, Emma; Rand, Jade; Rawlinson, Thomas; Rhead, Sarah; Robinson, Hannah; Ritchie, Adam J; Ross-Russell, Amy L; Saich, Stephen; Singh, Nisha; Smith, Catherine C; Snape, Matthew D; Song, Rinn; Tarrant, Richard; Themistocleous, Yrene; Thomas, Kelly M; Villafana, Tonya L; Warren, Sarah C; Watson, Marion E E; Douglas, Alexander D; Hill, Adrian V S; Lambe, Teresa; Gilbert, Sarah C; Faust, Saul N; Pollard, Andrew J; Aboagye, J.; Adams, K.; Ali, A.; Allen, E.; Allen, L.; Allison, J.; Andritsou, F.; Anslow, R.; Arbe-Barnes, E.H.; Baker, M.; Baker, N.; Baker, P.; Baleanu, I.; Barker, D.; Barnes, E.; Barrett, J.R.; Barrett, K.; Bates, L.; Batten, A.; Beadon, K.; Beckley, R.; Bellamy, D.; Berg, A.; Bermejo, L.; Berrie, E.; Beveridge, A.; Bewley, K.R.; Bijker, E.M.; Birch, G.; Blackwell, L.; Bletchly, H.; Blundell, C.; Blundell, S.; Bolam, E.; Boland, E.; Bormans, D.; Borthwick, N.; Boukas, K.; Bower, T.; Bowring, F.; Boyd, A.; Brenner, T.; Brown, P.; Brown-O'Sullivan, C.; Bruce, S.; Brunt, E.; Burbage, J.; Burgoyne, J.; Buttigieg, K.R.; Byard, N.; Puig, I.C.; Camara, S.; Cao, M.; Cappuccini, F.; Carr, M.; Carroll, M.W.; Cashen, P.; Cavey, A.; Chadwick, J.; Challis, R.; Charles, D.; Cho, J.; Cifuentes, L.; Clark, E.; Collins, S.; Conlon, C.P.; Coombes, N.S.; Cooper, R. (2020). Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, (), S0140673620324661–.
doi:10.1016/S0140-6736(20)32466-1
